Get started

PHARMA

METROPOLIS : In the best of health Metropolis post its results on 6th Feb did meet with some heavy profit booking that dragged the prices lower by 150 points. However, the momentum in this counter continues to remain upbeat. The dip provided a good opportunity to some strong hands to reenter and quickly place the stock back in contention. On the charts we note that the trends post a steady consolidation at higher levels is keen to take off. The charts reveal that the support offered by the KS line has proved to be quite good and the long body candle formation at the TS does augur well for the prices. With volumes building up we can expect the prices to begin a new journey towards the region of 1850 in the next few weeks. Looking at the Awesome oscillator we can observe that the trend is suggesting that there has been a pullback and it would be appropriate to enter at this moment.
NSE:METROPOLISLong
by Raja_Chart_Advise
Nifty Pharma - ready to move up after a consolidation.Following Nifty ATH, other sectoral indices too are moving up, forming multiple bullish patterns. Pharma sector which was once darling of investors, is attempting to catch up. Some of you might have experienced, how it makes wild moves. Pharma stocks are among most preferred ones, among FIIs, DIIs and HNIs. I guess having exposure to the sector is a necessary for every equity portfolio. Identify a mix of large and quality mid cap stocks and keep adding them at every dip.
NSE:CNXPHARMALong
by ipuneet
Auropharma - Pharma Traps at 800 Disclaimer ----------------------------- All investments involve risk, and the past performance of a security, industry, sector, market, financial product, trading strategy, or individual’s trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. ------------------------------------------------------------------------------------------------------------------------------------------ Trading Strategy Plan A Sell below 440 for targets 400 /350 /300 Plan B Buy Above 455 "If holds above 450 as a condition" for upside targets 475-480 & Above 480 for 500-510 & Above 520 for 530/540/550 Plan C If Plan B activates & stock reaches 500-510 zone where it finds resistance or upside hurdle -traders can sell once it starts moving back below 500 as condition. No selling if crosses above 500 & holds the level as support later. --------------------------------------------------------------------------------------------------------------------------------------- Last Video Idea - Click to see the video Elliottwaves - Will it repeat the fall of 2016 -------------------------------------------------------------------------------------------------------------------------------------- Thanks for watching the video & your support. Good Night!
NSE:AUROPHARMA
by WaveTalks
41
IPCA Labs - Go long- A comparison of its previous movement and predicted movement is provided here-in-below: - The last trend started from 2nd week of October, 2018 which lasted till March, 2019; in which the stock gave as good as 66% return - Note that from Oct to Jan, the stock was consolidating between the 50% and 61.8% retracement level. - The current trend begins from Feb 2019 and likely to end in Feb 2020. - Drawing an analogy from the previous trend and holding that the stock has consolidated between 50% & 61.8% of the possible target, the target converges with its all time resistance line at Rs - 1230 - The possible return comes to around 66% Technical Aspect - RSI is about to enter 65+ levels - MACD is highly positive
NSE:IPCALABLong
by surajagarwal15743